As early summer arrives in Chengdu, distinguished ophthalmology professionals gather from across the globe. The 5th International Refractive Surgery Symposium (IRSS) grandly convened in Chengdu, Sichuan Province from May 23 to 24. Centered on the theme Refractive Surgery, Leading Global Innovation, the forum assembled nearly 400 top ophthalmic specialists and scholars hailing from China, the United States, France, South Korea, Switzerland, Ireland, Brazil, Indonesia and numerous other nations.

Professor Wang Zheng, Fellow of the World College of Refractive Surgery & Visual Sciences, Academic Leader of Aier Eye Hospital Group’s Refractive Surgery Division, Chief President of Guangdong Regional Aier Hospitals and Distinguished Lead Expert of Dongguan Aier Refractive Department, presided over the summit.

Thanks to his groundbreaking academic researches and outstanding clinical outcomes, Professor Wang was named among the World’s Top 50 Most Influential Ophthalmologists 2026, one of only three mainland Chinese specialists on the list. A dedicated awards ceremony was held onsite to present the prestigious accolade, a high recognition of his profound academic attainments and remarkable clinical contributions to the industry.

Led by President Liu Fei, Director Chen Xiaobei and Deputy Director Yang Xiaofeng, the expert team from Dongguan Aier Eye Hospital’s Refractive Department attended this landmark international academic event upon official invitation. They engaged in in-depth exchanges with world-leading refractive specialists to discuss cutting-edge technologies and clinical practices, absorb the latest research findings and industrial updates, and bring these advanced achievements back to Dongguan to continuously upgrade medical services and safeguard local residents’ crisp eyesight.

Meanwhile, bolstered by solid clinical expertise, abundant surgical experience and core technological advantages built around three flagship refractive procedures, the Refractive Department of Dongguan Aier Eye Hospital claimed a string of prestigious team and individual honors at the summit, fully demonstrating its internationally recognized professionalism and industrial influence.

Honours Won & Core Technologies Authoritatively Certified

Dongguan Aier Eye Hospital Earns Multiple International Awards

Expert proficiency underpins reputable clinical outcomes and word-of-mouth credibility. At IRSS 2026, spearheaded by President Liu Fei and Director Chen Xiaobei, Dongguan Aier’s refractive team secured four authoritative industry awards:

• Annual Leading Hospital for EVO ICL Surgery

• SMILE pro Leading Surgeon Award

• Excellent Institution for Minimally Invasive SMILE Popular Science Campaign

• Advanced Refinement Award for All-in-One Refractive Sculpture (Full-Optic Refraction)

The hospital has won honors across its three flagship refractive solutions: next-gen robotic SMILE pro, Full-Optic Refraction and EVO ICL, comprehensively verifying the safety, professionalism and technological superiority of Dongguan Aier’s refractive surgery system.

As an authorized medical institution mastering all three mainstream corrective techniques — robotic SMILE pro, Full-Optic Refraction and EVO ICL with full official certification, Dongguan Aier customizes exclusive correction regimens tailored to patients’ myopia diopters, age groups and individual ocular conditions under the philosophy of One Customized Plan for One Unique Eye.

Led by President Liu Fei and Director Chen Xiaobei, the expert team consistently integrates frontline clinical experience with global pioneering innovations, upgrading refractive surgery from mere safety assurance toward safer, more precise and more comfortable vision correction, and delivering reliable personalized eyesight restoration plans for every myopic patient.

To date, Dongguan Aier has completed over 26,000 SMILE procedures, including more than 700 robotic SMILE pro surgeries, over 1,500 Full-Optic Refraction operations and upwards of 10,000 EVO ICL implantations (among which over 100 cases adopt upgraded EVO+ICL V5 lens). The three cutting-edge techniques have gained widespread recognition and trust among local patients with stable clinical application.

All Three Core Procedures Garner Official Accolades

Backed by the seasoned expert panel headed by President Liu Fei and Director Chen Xiaobei with tens of thousands of accumulated surgical cases, Dongguan Aier achieves full honors across robotic SMILE pro, Full-Optic Refraction and EVO ICL implantation. Doctors formulate exclusive surgical plans matching individual corneal morphology, myopia degree and daily visual demands, with each technique covering distinct clinical scenarios to satisfy diversified spectacle-removal needs:

Annual Leading Hospital for EVO ICL Surgery

Having specialized in myopia correction for 11 years in Dongguan, the hospital has performed more than 10,000 EVO ICL implantations to date under the supervision of the local pioneer ICL expert team led by President Liu Fei and Director Chen Xiaobei, maintaining top-tier regional surgical volume.

Marking another milestone in 2026, Dongguan Aier becomes the first hospital in Dongguan to obtain official certification for EVO+ICL (V5) implantation with priority access to premium intraocular lenses. It pioneers the introduction of this upgraded lens featuring enlarged optical zone and superior day-and-night visual quality to benefit local myopia patients with premium vision restoration.

SMILE pro Leading Surgeon Award & Excellent Institution for Minimally Invasive SMILE Popular Science Campaign

Dongguan Aier is the first local medical provider to launch next-generation robotic SMILE pro surgery. President Liu Fei, Director Chen Xiaobei and Deputy Director Yin Na hold full official certification across all SMILE-related qualification accreditations. Inheriting SMILE’s core strengths of flap-free minimally invasive design, SMILE pro leverages intelligent robotic surgical platform and automatic ocular tracking system to finish laser scanning within merely 10 seconds, featuring minimal tissue trauma, rapid postoperative recovery and lowered dry eye risks.

Within nearly one year after introducing SMILE pro to Dongguan, the department has accumulated over 700 robotic SMILE pro clinical cases, supported by a solid base of 26,000+ conventional SMILE surgeries, enabling safer, faster and smarter myopia correction services for local citizens.

Advanced Refinement Award for Full-Optic Refraction

Different from conventional laser correction focusing only on corneal parameters, Full-Optic Refraction adopts an innovative full-eye design philosophy by taking multiple overlooked intraocular optical factors into consideration to deliver comprehensive personalized vision correction.

As one of the earliest authorized cooperative hospitals nationwide, Dongguan Aier introduced Full-Optic Refraction to Dongguan back in May 2024 and remains the city’s sole licensed medical institution for this proprietary cutting-edge technique till now, providing internationally-standard customized correction solutions for local myopia sufferers. Notably, Director Chen Xiaobei performed Dongguan’s first Full-Optic Refraction surgery and has been accredited as a National Certified Expert for Full-Optic Refractive Surgery, helping patients achieve sharper-than-expected visual outcomes.

Dual Expert Accolades Highlight Exceptional Clinical Expertise of Core Specialists

President Liu Fei & Director Chen Xiaobei Receive Individual Honors

Continuous clinical refinement and inheritance of exquisite medical craftsmanship fuel professional breakthroughs. Empowered by robust hospital platforms and mature technical systems, core specialists keep advancing clinical practice and academic researches. President Liu Fei and Director Chen Xiaobei were separately conferred the EVO ICL Decade Partnership Award and EVO ICL Young Elite Award for outstanding clinical proficiency, abundant complex-case experience and long-term contributions to refractive industry, testifying the top-tier clinical capacity and nationwide influence of Dongguan Aier’s refractive team.

President Liu Fei – Recipient of EVO ICL Decade Partnership Award

With over three decades of ophthalmic clinical experience, President Liu Fei is a rare triple-board-qualified surgeon proficient in vitreoretinal surgery, cataract surgery and refractive correction across three core ophthalmic subspecialties. He accomplished Dongguan’s first-ever EVO ICL implantation in 2015, kicking off a new era of local refractive surgery. Back in 2019, he won the prestigious global EVO ICL 1000 Surgeon Award, an honor granted to only 22 elite specialists worldwide. His EVO ICL Decade Partnership Award recognizes his decade-long dedication to ICL technology and witnesses his consistent devotion to improving patients’ visual wellness with consummate medical skills and professional responsibility.

Director Chen Xiaobei – Recipient of EVO ICL Young Elite Award

Boasting nearly 20 years of clinical experience and over 6,000 completed ICL implantations, Director Chen Xiaobei sets a benchmark for young leading refractive surgeons. As one of Dongguan’s earliest ICL-certified specialists, she holds multiple authoritative titles including member of National Youth Expert Group for Phakic IOL Implantation and Dongguan’s first certified surgeon for upgraded EVO+ICL (V5) implantation nationwide. Her outstanding contributions to ICL clinical development earn her the EVO ICL Young Elite Award, safeguarding local residents’ clear vision with meticulous medical service.

Both institutional EVO ICL Annual Leading Hospital honor and the two individual expert awards are granted via rigorous multi-dimensional evaluation based on annual surgical output, clinical safety records, certified surgeon pool and long-term patient satisfaction scores, confirming Dongguan Aier’s world-class standards in ICL science popularization, standardized clinical application and technological innovation.

Academic Achievement Translates into Public Welfare to Make Advanced Eye Care Accessible to the Public

Director Chen Xiaobei Promotes Evidence-Based Myopia Correction via Public Welfare Initiatives

Academic advancement bears greater value when benefiting general public. The high-end summit for Zeiss next-gen robotic SMILE pro was successfully held alongside the 5th IRSS Forum, gathering top ophthalmic authorities, industrial leaders and mainstream media representatives to boost high-quality development of China’s refractive surgery sector.

Invited to the event, Director Chen Xiaobei took part in the launching ceremony of the 2026 Dream Forward · Minimally Invasive SMILE National Public Welfare Season. As Dongguan’s first surgeon performing robotic SMILE pro and one of the country’s earliest certified operators for this cutting-edge procedure, she devotes herself to popular science education on eye health and evidence-based myopia correction. Through serial public welfare lectures and science outreach campaigns, she corrects widespread misconceptions about refractive surgery, popularizes standardized spectacle-removal concepts and brings affordable advanced minimally invasive refractive techniques to adolescents and families across the community.

Craftsmanship Guards Eyesight for Crisp Vision

Every honor stands as authoritative validation of clinical competence; every international academic exchange serves to upgrade local medical services. The fruitful IRSS journey of Dongguan Aier’s refractive team showcases its prominent academic standing and technical prowess within the global refractive field and echoes Aier Eye Group’s founding mission: Advance clinical practice with academic breakthroughs, deliver affordable cutting-edge eye care to the general public.